Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series

John P. Palmer; Arief A. Suriawinata; Shaofeng Yan; Darcy A. Kerr; Muhammad Z. Afzal; Keisuke Shirai

doi:10.12659/AJCR.938537

18 November 2023 : Case report USA

Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series

Unusual or unexpected effect of treatment

John P. Palmer^1ADEF*, Arief A. Suriawinata^2BDE, Shaofeng Yan^2BDE, Darcy A. Kerr^2BDE, Muhammad Z. Afzal^1ABCE, Keisuke Shirai^1ADEF

DOI: 10.12659/AJCR.938537

Am J Case Rep 2023; 24:e938537

Authors information Article notes Copyright and License information

Background Case Reports Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 17. Case 6: (A) PET/CT obtained on July 14, 2020, showing a highly FDG-avid 1.9-cm left intraparotid lymph node consistent with nodal metastasis and an FDG-avid 3.1-cm right lower lobe lung mass consistent with melanoma metastasis. (B) PET/CT obtained on November 28, 2022, showing no evidence of tumor recurrence or metastasis.

Back to the Article

Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series

Your Privacy